January 16, 2025- Henry Schein, Inc. announced it has completed the acquisition of substantially all of the assets of Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). Henry Schein announced the agreement to acquire Acentus on November 20, 2024. Headquartered in Tampa, Florida, Acentus reports annual revenue of … [Read more...]
HealthTrust receives esteemed Modern Healthcare Best in Business Awards
January 16, 2025- HealthTrust Performance Group announced it has received two Modern Healthcare Best in Business Awards for its Advisory Services and Medical Device Management (MDM) solutions. Modern Healthcare recognized HealthTrust’s Advisory Services for its expertise and work in helping healthcare systems solve complex operational challenges, streamline processes and … [Read more...]
Cardinal Health to open new distribution center in Fort Worth, Texas
January 15, 2024- Cardinal Health announced construction is underway on a new distribution center in Fort Worth, Texas, which will support its at-Home Solutions business, a leading medical supplies provider that serves more than 5 million patients annually in the United States. The new 340,000 square foot distribution center will consolidate its two existing warehouses into … [Read more...]
BD names new Chief Accounting Officer and Controller
January 15, 2024- BD announced that Pamela Spikner has been named senior vice president, chief accounting officer and controller, effective January 20. In this role, Spikner will be responsible for all accounting policy and financial reporting for the company. She will report to Chris DelOrefice, executive vice president and chief financial … [Read more...]
Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System
January 15, 2024- Medtronic plc announced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension. This national coverage analysis was initiated by … [Read more...]
Intermountain Primary Children’s Hospital joins International Children’s Brain Tumor Network
January 15, 2024- Intermountain Primary Children’s Hospital has become the newest member institution of theChildren’s Brain Tumor Network (CBTN), a prestigious, international collaborative research effort aimed at accelerating treatments for children with brain tumors. Intermountain Primary Children’s Hospital now is among 34 institutions worldwide that have … [Read more...]
Respiratory virus activity remains elevated: Key updates
January 15, 2024- Respiratory illness activity remains high across the U.S., with emergency department visits and positive test rates rising for COVID-19, influenza and respiratory syncytial virus, according to Becker's. The CDC reported Jan. 13 that 29 states were reporting "high" levels of respiratory illness activity. Six states reported "very high" levels of respiratory … [Read more...]
Walgreens, Henry Schein, CVS, and more mobilize to assist communities impacted by LA wildfires
January 15, 2024- Many health systems and pharmacies have mobilized to assist the communities impacted by the Los Angeles wildfires, including Walgreens, Henry Schein, CVS, and more. Walgreens stated that the company is focused on the safety and well-being of patients, customers and team members and have taken precautions to support areas impacted by the Los Angeles wildfires, … [Read more...]
Henry Schein opens Henry Schein Cares Foundation 2025 Relief Fund to support the city of Los Angeles
January 14, 2024- Henry Schein, Inc. announced the opening of the Henry Schein Cares Foundation 2025 Relief Fund to support the Los Angeles area fires. Contributions will support the provision of critical health care supplies and resources to help people impacted by the wildfires throughout the city. The Company and Henry Schein Cares Foundation will donate an … [Read more...]
QuidelOrtho announces preliminary unaudited revenue for Fourth Quarter 2024
January 14, 2024- QuidelOrtho Corporation announced preliminary unaudited revenue for the fourth quarter ended December 29, 2024. The Company expects total reported revenues for the fourth quarter of 2024 to be in the range of approximately $702 million to $707 million, which would be in line with its previously announced 2024 financial guidance, including Labs revenue which is … [Read more...]